GreatCall Lively Mobile Recall Issued Due to Risk Emergency Button May Fail

Russell Maas

Add Your Comments

Nearly 45,000 Lively Mobile emergency call devices sold by GreatCall have been recalled, due to a risk they may fail to send out an alert even after the button is pushed.

The U.S. Consumer Product Safety Commission (CPSC) announced the GreatCall Lively Mobile recall on August 30, after routine testing by the manufacturing company detected the push button may fail to send a signal during an emergency.

While no injuries have been linked to the Lively Mobile button failures, many elderly and disabled individuals rely on the device to call for help in the event of a sudden emergency.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

The recall impacts Lively Mobile Plus model GCR4 emergency alert devices, which are designed with a call button that is supposed to send a signal for help when pushed. The products are often used by those prone to fall hazards or medical conditions which may require emergency medical response.

The devices are worn on a magnetic lanyard around a consumer’s neck to detect falls, or can be clipped on to the individuals pocket or other accessories for convenience to communicate a signal in an emergency or assistance required situation.

In the event the device fails to send a call signal, an individual who has experienced a fall or other potentially life-threatening emergency could be stranded without assistance.

The recall affects Lively Mobile Plus emergency alert devices with model number GCR4 and date code 19.01 or 19.03. The products were manufactured in China by Borqs Hong Kong Limited and Shenzhen Saidaxin Technology Co. Ltd. They were imported and distributed for sale across the U.S. by GreatCall Inc., of San Diego, California.

The devices were sold at Best Buy and Walmart stores nationwide and online at www.greatcall.com and www.amazon.com from April 2019 through May 2019 for between $25 and $50.

Customers are being asked to immediately stop using the recalled Lively Mobile Plus devices and contact GreatCall customer service at 800-359-1791 or email them at customerservice@greatcall.com for information on how to receive a full refund.

Russell Maas
Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development.

Tags: Medical Alert Device Recall

More Lawsuit Stories

0 Comments

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Nearly 4,000 Bard PowerPort Lawsuits Now Filed Amid Upcoming Bellwether Trials
C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.
Dupixent CTCL Studies Highlighted Cancer Risks For Years Lawsuit
A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.
MORE ABOUT: DUPIXENT LAWSUIT
Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims
Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.